Videos

Vibeke Strand, MD, on the Future of JAK Inhibitors for Immune-Mediated Inflammatory Diseases

06/23/2019

In this video, Vibeke Strand, MD, highlights current JAK inhibitors for the treatment of immune-mediated inflammatory diseases, how they may be used in the future, and more.

Vibeke Strand, MD, is a clinical rheumatologist in California, as well as a biopharmaceutical consultant.

For more content, visit the Interdisciplinary Autoimmune Summit resource center

Published in partnership with

Stay in the Know

Rheumatology & Arthritis Newsletter

Partner Spotlight

Axial Involvement in SpA: A Patient-Centered Exploration, Chapter 1

Popular Articles

Study: Celecoxib vs Ibuprofen vs Naproxen for Treating RA and OA

11/18/2016

Amanda Balbi ;

Celecoxib, a selective Cox-2 nonsteroidal anti-inflammatory drug (NSAID), is non-inferior to prescription doses of ibuprofen and naproxen for treating patients with osteoarthritis (OA) and rheumatoid arthritis (RA), according to a...

Celecoxib, a selective Cox-2...

11/18/2016

Rheumatology & Arthritis

ICIs Can Trigger Rheumatic Symptoms Among Patients With Cancer

05/13/2011

Immune checkpoint inhibitors (ICIs) can often trigger inflammatory syndromes and immune‐related adverse events (IRAEs) in patients with cancer, new research has shown. Clinicians witness numerous rheumatic IRAEs reports, including...

Immune checkpoint inhibitors...

05/13/2011

Rheumatology & Arthritis

Transcript: Integrating Complementary Medicine and Herbs Into the Management of Rheumatic Diseases

11/20/2010

Neha Shah: Hello. I’m Neha Shah from Stanford University. I’m an assistant professor in rheumatology and immunology, as well as the Rheumatology Fellowship Program director. At the ACR, I gave a talk focusing on complementary medicine and...

Neha Shah: Hello. I’m Neha Shah...

11/20/2010

Rheumatology & Arthritis

Podcast Series

Lisa Sammaritano, MD, on Lupus and Reproductive Health: Part 2

04/29/2022

In the second podcast of a 2-part discussion, Dr Sammaritano, from Weill Cornell Medicine and the Hospital for Special Surgery in New York, discusses the challenges of caring for patients with lupus during pregnancy, including the safest...

In the second podcast of a...

04/29/2022

Rheumatology & Arthritis

News

Research Shows Tocilizumab Stabilizes ILD

08/12/2021

The focuSSced study revealed that even participants with severe interstitial lung disease related to systemic sclerosis demonstrated preservation of lung function during the 48-week trial.

The focuSSced study revealed...

08/12/2021

Rheumatology & Arthritis

Vibeke Strand, MD, on the Future of JAK Inhibitors for Immune-Mediated Inflammatory Diseases

Stay in the Know

Partner Spotlight

Popular Articles

Specialties

Events

Year Round Education

HMP Global Products